618 related articles for article (PubMed ID: 17698271)
1. Cost-effectiveness analysis and formulary decision making in England: findings from research.
Williams IP; Bryan S
Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
[TBL] [Abstract][Full Text] [Related]
2. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
3. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
Eddama O; Coast J
Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
[TBL] [Abstract][Full Text] [Related]
4. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
6. From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap.
Legood R; Wolstenholme J; Gray A
Health Policy; 2009 Feb; 89(2):193-200. PubMed ID: 18619702
[TBL] [Abstract][Full Text] [Related]
7. Patients' views of explicit rationing: what are the implications for health service decision-making?
Devlin N; Appleby J; Parkin D
J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
Lopert R
Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
[TBL] [Abstract][Full Text] [Related]
9. What reasons do those with practical experience use in deciding on priorities for healthcare resources? A qualitative study.
Hasman A; McIntosh E; Hope T
J Med Ethics; 2008 Sep; 34(9):658-63. PubMed ID: 18757635
[TBL] [Abstract][Full Text] [Related]
10. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
Ijzerman MJ; Steuten LM
Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
[TBL] [Abstract][Full Text] [Related]
11. The clinical context of technology assessment.
Smits HL
J Health Polit Policy Law; 1984; 9(l):31-40. PubMed ID: 11650667
[TBL] [Abstract][Full Text] [Related]
12. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
Al MJ; Feenstra T; Brouwer WB
Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
[TBL] [Abstract][Full Text] [Related]
13. Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?
Anell A; Persson U
Eur J Health Econ; 2005 Sep; 6(3):274-9. PubMed ID: 15968561
[TBL] [Abstract][Full Text] [Related]
14. Are economic evaluations and health technology assessments increasingly demanded in times of rationing health services? The case of the Argentine financial crisis.
Rubinstein A; Belizán M; Discacciati V
Int J Technol Assess Health Care; 2007; 23(2):169-76. PubMed ID: 17493302
[TBL] [Abstract][Full Text] [Related]
15. Challenges ahead for federal technology assessment.
Neumann PJ
Health Aff (Millwood); 2007; 26(2):w150-2. PubMed ID: 17259197
[TBL] [Abstract][Full Text] [Related]
16. Managing to manage healthcare resources in the English NHS? What can health economics teach? What can health economics learn?
Bate A; Donaldson C; Murtagh MJ
Health Policy; 2007 Dec; 84(2-3):249-61. PubMed ID: 17512086
[TBL] [Abstract][Full Text] [Related]
17. Role of technology assessment in health benefits coverage for medical devices.
Braslow NM; Shatin D; McCarthy DB; Newcomer LN
Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
[TBL] [Abstract][Full Text] [Related]
18. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
Williams I; McIver S; Moore D; Bryan S
Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
[TBL] [Abstract][Full Text] [Related]
19. Resource allocation and health technology assessment in Australia: views from the local level.
Gallego G; van Gool K; Kelleher D
Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
[TBL] [Abstract][Full Text] [Related]
20. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
Bryan S; Williams I; McIver S
Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
